Empowered Relief® for Cancer Survivors With Chronic Pain
RecruitingNot applicableNCT07578376
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This randomized controlled study to examine the efficacy of ER class in cancer survivors with chronic pain. Eligible participants will be randomly assigned to a ER class or a waitlist control condition. We will recruit 250 participants with a goal of having 200 completers (20% attrition). Participants in the control condition will be invited to attend ER class after the 3-month observation period.
Study details
- Official title
- Feasibility and Preliminary Efficacy of Empowered Relief® for Cancer Survivors With Chronic Pain
- Conditions
- Chronic Pain Due to Cancer
- Pain Catastrophizing
- Interventions
- Behavioral: Empowered Relief Course (Zoom)
- Sponsor
- University of Oklahoma
- Start date
- 2026-06
- Primary completion
- 2029-12-31
- Sex
- All
- Age range
- from 18 Years to 120 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: History of cancer diagnosis, completion of active cancer treatment, cancer free at the time of enrollment, experience of body pain most or every day, pain duration at least 3 months, and English fluency. Exclusion Criteria: Significant psychological and cognitive impairment that limits one's ability to complete study tasks (completion of online survey, attending the zoom-based ER class). Life-threatening acute illness (e.g., infection, heart attack, injury), and no access to a computer, a smartphone or a tablet.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07578376